Green tea found to reduce rate of some GI cancers

October 31, 2012

Women who drink green tea may lower their risk of developing some digestive system cancers, especially cancers of the stomach/esophagus and colorectum, according to a study led by researchers from Vanderbilt-Ingram Cancer Center.

The study by lead author Sarah Nechuta, Ph.D., MPH, assistant professor of Medicine, was published online in advance of the Nov. 1 edition of the . Wei Zheng, M.D., Ph.D., MPH, professor of Medicine, chief of the Division of Epidemiology and director of the Vanderbilt Epidemiology Center, was the principal investigator for the study.

To determine green tea's impact on , the investigators surveyed women enrolled in the Shanghai Women's Health Study, a population-based study of approximately 75,000 middle-aged and older Chinese women. During the initial interview participants were asked if they drank tea, the type of tea consumed and how much they consumed. Most of the Chinese women reported drinking primarily green tea.

The researchers found that regular , defined as tea consumption at least three times a week for more than six months, was associated with a 17 percent reduced risk of all combined. A further reduction in risk was found to be associated with an increased level of tea drinking. Specifically, those who consumed about two to three cups per day (at least 150 grams of tea per month) had a 21 percent reduced risk of digestive system cancers.

The trend toward fewer digestive cancers was strongest for stomach/esophageal and .

"For all digestive system cancers combined, the risk was reduced by 27 percent among women who had been drinking tea regularly for at least 20 years," said Nechuta. "For colorectal cancer, risk was reduced by 29 percent among the long-term tea drinkers. These results suggest long-term cumulative exposure may be particularly important."

Tea contains polyphenols or that include catechins like and ECG. Catechins have antioxidant properties and may inhibit cancer by reducing DNA damage and blocking tumor cell growth and invasion.

The researchers also asked about other lifestyle factors including the kinds of food eaten regularly, exercise habits, education level and occupation. Women who had ever smoked or who drank alcohol were excluded from the study.

Regular in the study were younger, had higher education, exercised more and consumed more fruits and vegetables. While the researchers adjusted for these factors, they could not rule out an effect from these and other unmeasured lifestyle habits.

The study was conducted in nonsmoking and nondrinking Chinese women to minimize the potential influence of these two risk factors on the results for tea consumption and digestive system cancer risk.

Explore further: Tea drinkers may be at greater risk of prostate cancer: study

Related Stories

Tea drinkers may be at greater risk of prostate cancer: study

June 19, 2012
(Medical Xpress) -- Men who are heavy tea drinkers may be more likely to develop prostate cancer, according to research from scientists at the University of Glasgow which is published in the journal Nutrition and Cancer.

Green tea reduces cholesterol risk

July 8, 2011
(Medical Xpress) -- In a recent study published in the American Journal of Clinical Nutrition, Xin-Xin Zheng reports that green tea reduces LDL and total cholesterol. This could explain the reasoning behind green tea’s ...

Coffee and tea consumption reduce MRSA risk

July 15, 2011
While an apple a day may keep the doctor away, new research published in the Annals of Family Medicine say that hot tea or coffee may keep the methicillin-resistant Staphyloccus aureus, or MRSA, bug away, or at least out ...

Recommended for you

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Using artificial intelligence to improve early breast cancer detection

October 17, 2017
Every year 40,000 women die from breast cancer in the U.S. alone. When cancers are found early, they can often be cured. Mammograms are the best test available, but they're still imperfect and often result in false positive ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.